Buprenorphine for human immunovirus-positive opiate-dependent patients.
Montoya
I D
ID
Umbricht
A
A
Preston
K L
KL
D015492:AIDS Serodiagnosis; D000286:Administration, Sublingual; D000328:Adult; D002047:Buprenorphine / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006679:HIV Seropositivity / Q000523:psychology / Q000534:rehabilitation*; D006556:Heroin Dependence / Q000523:psychology / Q000534:rehabilitation; D006801:Humans; D008297:Male; D009293:Opioid-Related Disorders / Q000523:psychology / Q000534:rehabilitation*; D015819:Substance Abuse, Intravenous / Q000523:psychology / Q000534:rehabilitation; D016896:Treatment Outcome
D002047:Buprenorphine